Bifogade filer
FM_10_24UK_020524
Kurs & Likviditet
Kalender
| 2024-11-14 | Kvartalsrapport 2024-Q3 |
| 2024-08-23 | Kvartalsrapport 2024-Q2 |
| 2024-05-03 | Kvartalsrapport 2024-Q1 |
| 2024-03-15 | Ordinarie utdelning ALK B 0.00 DKK |
| 2024-03-14 | Årsstämma 2024 |
| 2024-02-08 | Bokslutskommuniké 2023 |
| 2023-11-15 | Kvartalsrapport 2023-Q3 |
| 2023-08-24 | Kvartalsrapport 2023-Q2 |
| 2023-05-09 | Kvartalsrapport 2023-Q1 |
| 2023-03-20 | Ordinarie utdelning ALK B 0.00 DKK |
| 2023-02-03 | Bokslutskommuniké 2022 |
| 2022-11-10 | Kvartalsrapport 2022-Q3 |
| 2022-08-11 | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | Kvartalsrapport 2022-Q1 |
| 2022-03-28 | Split ALK B 1:20 |
| 2022-03-17 | Ordinarie utdelning ALK B 0.00 DKK |
| 2022-03-16 | Årsstämma 2022 |
| 2022-02-08 | Bokslutskommuniké 2021 |
| 2021-11-11 | Kvartalsrapport 2021-Q3 |
| 2021-08-11 | Kvartalsrapport 2021-Q2 |
| 2021-05-05 | Kvartalsrapport 2021-Q1 |
| 2021-03-19 | Ordinarie utdelning ALK B 0.00 DKK |
| 2021-03-18 | Årsstämma 2021 |
| 2021-02-10 | Bokslutskommuniké 2020 |
| 2020-11-11 | Kvartalsrapport 2020-Q3 |
| 2020-08-12 | Kvartalsrapport 2020-Q2 |
| 2020-05-06 | Kvartalsrapport 2020-Q1 |
| 2020-03-12 | Ordinarie utdelning ALK B 0.00 DKK |
| 2020-03-11 | Årsstämma 2020 |
| 2020-02-05 | Bokslutskommuniké 2019 |
| 2019-11-07 | Kvartalsrapport 2019-Q3 |
| 2019-08-13 | Kvartalsrapport 2019-Q2 |
| 2019-05-09 | Kvartalsrapport 2019-Q1 |
| 2019-03-14 | Ordinarie utdelning ALK B 0.00 DKK |
| 2019-03-13 | Årsstämma 2019 |
| 2019-02-07 | Bokslutskommuniké 2018 |
| 2018-11-09 | Kvartalsrapport 2018-Q3 |
| 2018-08-15 | Kvartalsrapport 2018-Q2 |
| 2018-05-04 | Kvartalsrapport 2018-Q1 |
| 2018-03-13 | Ordinarie utdelning ALK B 0.00 DKK |
| 2018-03-12 | Årsstämma 2018 |
| 2018-02-06 | Bokslutskommuniké 2017 |
| 2017-11-10 | Kvartalsrapport 2017-Q3 |
| 2017-08-16 | Kvartalsrapport 2017-Q2 |
| 2017-05-09 | Kvartalsrapport 2017-Q1 |
| 2017-03-16 | Ordinarie utdelning ALK B 5.00 DKK |
| 2017-03-15 | Årsstämma 2017 |
| 2017-02-07 | Bokslutskommuniké 2016 |
| 2016-11-10 | Kvartalsrapport 2016-Q3 |
| 2016-08-16 | Kvartalsrapport 2016-Q2 |
| 2016-05-04 | Kvartalsrapport 2016-Q1 |
| 2016-03-11 | Ordinarie utdelning ALK B 5.00 DKK |
| 2016-03-10 | Årsstämma 2016 |
| 2016-02-09 | Bokslutskommuniké 2015 |
| 2015-11-12 | Kvartalsrapport 2015-Q3 |
| 2015-08-18 | Kvartalsrapport 2015-Q2 |
| 2015-05-05 | Kvartalsrapport 2015-Q1 |
| 2015-03-13 | Ordinarie utdelning ALK B 5.00 DKK |
| 2015-03-12 | Årsstämma 2015 |
| 2015-02-09 | Bokslutskommuniké 2014 |
| 2014-11-14 | Kvartalsrapport 2014-Q3 |
| 2014-08-13 | Kvartalsrapport 2014-Q2 |
| 2014-05-08 | Kvartalsrapport 2014-Q1 |
| 2014-03-13 | Ordinarie utdelning ALK B 5.00 DKK |
| 2014-03-12 | Årsstämma 2014 |
| 2014-02-05 | Bokslutskommuniké 2013 |
| 2013-11-08 | Kvartalsrapport 2013-Q3 |
| 2013-08-14 | Kvartalsrapport 2013-Q2 |
| 2013-05-03 | Kvartalsrapport 2013-Q1 |
| 2013-03-13 | Ordinarie utdelning ALK B 5.00 DKK |
| 2013-03-12 | Årsstämma 2013 |
| 2013-02-05 | Bokslutskommuniké 2012 |
| 2012-11-12 | Kvartalsrapport 2012-Q3 |
| 2012-08-16 | Kvartalsrapport 2012-Q2 |
| 2012-05-10 | Kvartalsrapport 2012-Q1 |
| 2012-03-28 | Ordinarie utdelning ALK B 5.00 DKK |
| 2012-03-27 | Årsstämma 2012 |
| 2012-02-22 | Bokslutskommuniké 2011 |
| 2011-11-11 | Kvartalsrapport 2011-Q3 |
| 2011-08-16 | Kvartalsrapport 2011-Q2 |
| 2011-05-10 | Kvartalsrapport 2011-Q1 |
| 2011-04-04 | Ordinarie utdelning ALK B 5.00 DKK |
| 2011-04-01 | Årsstämma 2011 |
| 2010-03-29 | Ordinarie utdelning ALK B 5.00 DKK |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the 2024 full-year financial outlook has been updated.
Revenue is now expected to grow by 10-13% in local currencies (previously: 9-12%). The full-year financial outlook has been updated mainly to reflect the recent development in European tablet sales.
The EBIT margin is still expected to improve to 17-19% but the earnings outlook now includes one-off costs of approximately DKK 60 million related to optimization initiatives, whereas no such costs were included in the original outlook from February 8, 2024.
ALK has decided to advance the release of its first quarter results. The Q1 report, originally due for 3 May 2024, will be published today, 2 May 2024. The previously announced presentation for investors and analysts will still take place on 3 May 2024 at 12:30 CET.
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Maiken Riise Andersen, tel. +45 5054 1434
This information is information that ALK is obliged to make public pursuant to the EU Market Abuse Regulation.
About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,900 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.